Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 88072

2 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
May 27, 2021
Product types
Device
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Cell Marque Corporation

Dossier provenance

Source snapshots represented here

  • openFDA Device Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
  • openFDA Device Recall event_date_initiated coverage June 01, 1997–June 30, 2026

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

2 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

device · product 1 of 2

Cell Marque, RabMAb,CD17, c-kit (YR145) Rabbit Monoclonal Primary Antibody, REF: 117R-18, IVD, CE, GTIN: 00841683123798

Z-2105-2021
Recall number
Z-2105-2021
Initiated
May 27, 2021
Classification
Class II
Status
Terminated
Recalling firm
Cell Marque Corporation
Quantity
41 kits

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Product distributed for use as an In-vitro Diagnostics without FDA clearance

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Process control

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Product distributed for use as an In-vitro Diagnostics without FDA clearance

Code information

Lot Numbers: 0000058081/ Exp: 31 Dec 2021, 0000072580/ Exp: 30 Sep 2021, 0000090505/ Exp: 30 Sep 2022, 0000121052/ Exp: 31 May 2023

Distribution pattern

US: AL, AR, AZ, CA, FL, HI, ID, IL, KY, MN, MT, NC, NH, NY, PA, SC, VA, WI OUS: N/A

device · product 2 of 2

Cell Marque Antibodies, MSH6 (44), Mouse Monoclonal Antibody, REF: 287M-10, IVD, CE, GTIN: 00841683104513

Z-2106-2021
Recall number
Z-2106-2021
Initiated
May 27, 2021
Classification
Class II
Status
Terminated
Recalling firm
Cell Marque Corporation
Quantity
2 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Product distributed for use as an In-vitro Diagnostics without FDA clearance

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Process control

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Product distributed for use as an In-vitro Diagnostics without FDA clearance

Code information

Lot Number: 0000101423

Distribution pattern

US: AL, AR, AZ, CA, FL, HI, ID, IL, KY, MN, MT, NC, NH, NY, PA, SC, VA, WI OUS: N/A